RTW Biotech Opportunities Ltd Appointment of Senior Independent Director
10 Dicembre 2024 - 8:00AM
RNS Regulatory News
RNS Number : 4808P
RTW Biotech Opportunities Ltd
10 December 2024
LEI:
549300Q7EXQQH6KF7Z84
10 December 2024
RTW Biotech Opportunities
Ltd
(the "Company")
Appointment of Senior
Independent Director
The Company is pleased to announce
that Baroness Nicola Blackwood has been appointed as Senior
Independent Non-Executive Director with effect from 9 December
2024.
For
Further Information:
|
RTW
Investments, LP
|
+44
(0)20 7959 6361
|
|
Woody Stileman, Managing
Director
Krisha McCune, Director, Investor
Relations
|
|
|
|
|
About
Baroness Nicola Blackwood
Nicola was appointed to the board of
the Company on 11th July 2024. She is a leader in
science and entrepreneurship. She is a member of the House of
Lords, and Chair of Genomics England and Oxford University
Innovation. Since 2023, she has been a Supervisory Board member of
the biotechnology company, BioNTech. Nicola served as Minister for
Innovation in the Department for Health and Social Care under two
Prime Ministers where she led on Lifesciences, NHS Data and Digital
Transformation, and Global Health Security. She was the first
female MP for Oxford and was elected by MPs of all parties to Chair
the Commons Science and Tech Committee. She remains one of the
youngest committee chairs in British history and the only woman to
have chaired the Commons Science & Tech Committee.
About
RTW Biotech Opportunities Ltd:
RTW Biotech Opportunities Ltd (LSE:
RTW) is an investment fund focused on identifying transformative
assets with high growth potential across the biopharmaceutical and
medical technology sectors. Driven by a long-term approach to
support innovative businesses, RTW Biotech Opportunities Ltd
invests in companies developing next-generation therapies and
technologies that can significantly improve patients' lives. RTW
Biotech Opportunities Ltd is managed by RTW Investments, LP, a
leading healthcare-focused
entrepreneurial investment firm with
deep scientific expertise and a strong track record of supporting
companies developing life-changing therapies.
Visit the website
at www.rtwfunds.com/rtw-biotech-opportunities-ltd for
more information.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
BOAGPGMPPUPCUQU
Grafico Azioni Rtw Biotech Opportunities (LSE:RTW)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Rtw Biotech Opportunities (LSE:RTW)
Storico
Da Gen 2024 a Gen 2025
